Skip to content

Compare

Zepbound vs Wegovy

Last reviewed: September 2026

Zepbound is tirzepatide; Wegovy is semaglutide. The same two drugs are also sold as Mounjaro and Ozempic for type 2 diabetes. Here is how they compare, head to head.

Head-to-head weight loss

From the only large trial that directly compared these two drugs. 751 adults with obesity, 72 weeks at maximum dose.

Zepbound / Mounjaro(tirzepatide)20.2%(~48 lbs)
Wegovy / Ozempic(semaglutide)13.7%(~33 lbs)
Tirzepatide showed higher average weight loss in this direct comparison. Individual results vary substantially.

That is the headline number. But neither drug is universally "better" — they differ on heart evidence, cost, and form. Here is the fuller picture.

Weight loss at maximum approved dose

Including the oral semaglutide pill, which was not part of the head-to-head trial.

Zepbound(tirzepatide injection)20.9%(~50 lbs)
Oral Wegovy(semaglutide pill)16.6%(~40 lbs)
Wegovy(semaglutide injection)14.9%(~36 lbs)
For a 240 lb person. Averages from published studies.

Monthly cost

The oral pill option is cheaper than either injection's self-pay price.

Oral Wegovy(semaglutide pill)$149–$299/mo
Zepbound(via LillyDirect, self-pay)$299–$449/mo
Wegovy(semaglutide injection, via NovoCare self-pay)$349–$399/mo
Manufacturer self-pay prices; list prices without those savings programmes are higher for both injections. Insurance coverage varies.

Side effects comparison

From each drug's main weight loss trial. All stomach side effects are most common in the first 4–8 weeks and usually fade.

Nausea
Tirzepatide31%
Semaglutide44%
Diarrhea
Tirzepatide23%
Semaglutide30%
Vomiting
Tirzepatide18%
Semaglutide25%
Constipation
Tirzepatide12%
Semaglutide24%
Quit due to side effects
Tirzepatide6%
Semaglutide7%
Tirzepatide had lower rates across all stomach side effects in trials. Both drugs use slow dose escalation to minimize symptoms.

Beyond weight loss

Heart protection

  • Semaglutide — 20% reduction in major heart events — proven in a large 17,604-person trial
  • Tirzepatide — Heart safety confirmed — heart benefit trial in progress

Form & convenience

  • Tirzepatide — Weekly injection only — no food timing restrictions
  • Semaglutide — Weekly injection OR daily pill — pill needs 30-min fasting window

Side effects

  • Nausea (semaglutide)44%
  • Nausea (tirzepatide)31%
  • Quit due to side effects~7%

Usually peaks weeks 2–4, fades by week 8–12

Prefer a pill over injections?

Two oral GLP-1 pills are now FDA-approved: Oral Wegovy (~16.6% weight loss, from $149/month) and Foundayo (~12.4% weight loss, no food restrictions).

See the Oral Wegovy vs Foundayo comparison →

Common questions

Written and maintained by one person · Built with agentic AI tools · Every number checked against the cited trial · Not medical advice

How this site is built →

Not sure where to start? Our 2-minute quiz can help.

Take the quiz →

Next step most people take

Built with agentic AI tools and not a substitute for medical advice

Last reviewed:

Was this page helpful?
Medical disclaimer: This website is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare provider before starting, stopping, or changing any treatment. Prices shown are United States self-pay or list prices and vary by insurance and country.